RetractedArticleOncology letters2017

Resistance to the mTOR inhibitor everolimus is reversed by the downregulation of survivin in breast cancer cells.

Ludovica Taglieri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.